Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a gentle electric device ease chronic neck pain without drugs?

NCT ID NCT07742228

Symptom relief Sponsor: Hopital Foch Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time

Summary

This trial investigates whether SCENAR therapy, a non-invasive electrotherapy device, can improve disability, mobility, and pain in adults with chronic non-specific neck pain lasting at least three months. Participants will receive either active SCENAR sessions or a sham (inactive) device to compare effects. The study focuses on changes in neck-related disability and pain intensity over the treatment period.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
SCENAR device therapy (a non-invasive electrotherapy device applied to the neck)
What this could lead to
If effective, SCENAR therapy could offer a drug-free option to reduce neck pain and disability, potentially reducing reliance on medications.
What could go wrong
This is an early-stage trial with a modest number of participants. The device may not outperform a sham treatment, and results may not apply to all neck pain sufferers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 76 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Jul 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male or female participants aged 18 years or older * Patients with chronic non-specific cervical spine pain, including cervicobrachial neuralgia, persisting for at least 3 months, with no identifiable underlying cause requiring specific treatment. * Patients who attended a pain clinic consultation or were referred to a pain specialist during hospitalization. * Neck Disability Index (NDI) score of at least 30% (≥15 points). * Written informed consent provided prior to study participation. * Patient affiliated to a national health insurance Exclusion Criteria: * Pregnant women * Skin conditions preventing SCENAR use (wounds, recent scars, skin infections) * Initiation or change of analgesic treatment within 15 days prior to inclusion or during the study * Cervical pain related to inflammatory (spondyloarthropathy, rheumatoid arthritis, chondrocalcinosis), traumatic (fractures, dislocations), tumor-related (metastases, myeloma), infectious (spondylodiscitis), or neurological (intramedullary or posterior fossa tumor) causes * Previous SCENAR or ECOMODYN session * Implanted pacemaker or defibrillator * Inability to understand French * Adults under legal protection * Individuals deprived of liberty or under guardianship

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cervicalgia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Chronic Pain chronic pain syndrome Neck Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cervicalgia Chronic pain Neck pain

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hôpital Foch

    RECRUITING

    Suresnes, Île-de-France Region, 92150, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.